Buprenorphine/naloxone Treatment in Primary Care is Associated with Decreased HIV Risk Behaviors

Methadone treatment reduces HIV risk but the effects of primary care-based buprenorphine/naloxone on HIV risk are unknown. The purpose of the current study was to determine whether primary care-based buprenorphine/naloxone was associated with decreased HIV risk behavior. We conducted a longitudinal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sullivan, Lynn E., Moore, Brent A., Chawarski, Marek C., Pantalon, Michael V., Barry, Declan, O'Connor, Patrick G., Schottenfeld, Richard S., Fiellin, David A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2587397/
https://ncbi.nlm.nih.gov/pubmed/17933486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2007.08.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi